openPR Logo
Press release

Active Pharmaceutical Ingredient Market - Comprehensive Insights by Demand Status, Industry Share, Opportunities Forecast to 2027

05-25-2022 09:53 AM CET | Health & Medicine

Press release from: UnivDatos Market Insights (UMI)

Active Pharmaceutical Ingredient Market

Active Pharmaceutical Ingredient Market

Global active pharmaceutical ingredient market is expected to witness a CAGR of around 6% during the forecast period. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects. Some drugs have multiple active pharmaceutical ingredients. The rising prevalence of the various diseases coupled with the COVID-19 pandemic is expected to drive the market for active pharmaceutical ingredients. Furthermore, the surging investments in research and development of targeted, specific drug, and pharmacogenetic drugs is also expected to support market growth. Worldwide, the increase in chronic diseases results in an increased demand for the treatment and has positive impacts on the market of drug manufacturing. For instance, Istodax, a drug registered by Celgene Co. in 2009 for cancer (Cutaneous T-Cell Lymphoma) witnessed a 30% growth in 2018 compared with 2010 which accounted for US$ 16 million in 2010 and reached US$63 million in 2018.

According to 'UnivDatos Market Insights (UMI)' research report "Active Pharmaceutical Ingredient Market Analysis, 2020", the Active Pharmaceutical Ingredient market is projected to grow at a CAGR of ~6% during 2021-27F.

Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=20418

Based on synthesis, the market is bifurcated into biotech and synthetic. In the forecast period, the biotech segment is expected to witness significant growth. This is mainly due to the rising focus on increasing the accuracy of biopharmaceutical drugs along with the surging investments in biotechnology research is driving the market. Furthermore, these drugs also provide patient-specific treatments which increase the efficiency of the drug with minimal side effects.

On the basis of manufacturer type, the market is categorized into merchant APIs and captive APIs. Among the two, the captive API is expected to witness significant growth during the forecast period. This can be attributed to the improved marketing strategies along with the increased connectivity coupled with innovations in the manufacturing sector. Furthermore, the increasing government investments in pharmaceutical industries in developing countries such as India, China, Brazil, and Mexico also contribute to the growth of captive APIs.

Based on drug type, the active pharmaceutical ingredient market has been bifurcated into generic APIs and innovative APIs. Amongst them, the market for innovative APIs is expected to grow at a significant rate during the forecast period. The rising prevalence of novel diseases and increasing demand for the more targeted and effective drugs for the treatment of various chronic diseases is expected to drive the market.

On the basis of application, the market is categorized into communicable diseases, oncology, diabetes, cardiovascular diseases (CVDs), pain management, respiratory diseases, and others. Among them, the cardiovascular segment dominated the market in 2020 due to the increasing prevalence of cardiovascular disorders and increasing awareness about the severity of heart diseases. However, the oncology segment is expected to witness growth in the foreseeable future. The sedentary lifestyle, increase cases of alcohol and tobacco abuse, and increasing pollution are some key factors responsible for the rising cases of chronic diseases such as cancer and diabetes across the world. Thus, need for effective treatment and drugs is expected to drive the API market during the forecast period.

Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=20418

North America to witness Significant Growth
For a better understanding of the market adoption of the Active Pharmaceutical Ingredient Industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), and Rest of World. During the forecast period, North America is expected to witness the highest CAGR during the forecast period. In addition, the higher geriatric population coupled with the rising number of patients with chronic diseases offer immense opportunities for market players to develop APIs. Furthermore, increasing investment in the biotechnology and biopharmaceutical industry along with rising healthcare expenditure in the region are some other major factors driving the North American API market.

According to UnivDatos Market Insights (UMI)', the key players with a considerable market share in the market are Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Cipla, Inc., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., and Dr. Reddy's Laboratories Ltd. The players are focused on launching new solutions and services, partnerships, and collaborations with major companies expanding their geographical reach to get a competitive edge in the industry.

"Active Pharmaceutical Ingredient Market Analysis, 2020" provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Active Pharmaceutical Ingredient providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors' capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us - https://univdatos.com/report/active-pharmaceutical-ingredient-market/

Market Segmentation:
1. By Synthesis (Biotech and Synthetic)
2. By Manufacturer Type (Merchant APIs and Captive APIs)
3. By Drug Type (Generic APIs and Innovative APIs)
4. By Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases (CVDs), Pain Management, Respiratory Diseases, and Others)
5. By Region (North America, Europe, Asia-Pacific, Rest of the World)
6. By Company (Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Cipla, Inc., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., and Dr. Reddy's Laboratories Ltd)

Key questions answered in the study:
1. What are the current and future trends of the Active Pharmaceutical Ingredient industry?
2. How the industry has been evolving in terms of Manufacture type and Application?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Active Pharmaceutical Ingredient industry?
5. What is the customer orientation, purchase behavior, and expectations from the Active Pharmaceutical Ingredient firms across various regions?

Contact us:
UnivDatos Market Insights (UMI)
Email: sales@univdatos.com
Web: https://univdatos.com
Ph: +91 7838604911

About Us:
UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Active Pharmaceutical Ingredient Market - Comprehensive Insights by Demand Status, Industry Share, Opportunities Forecast to 2027 here

News-ID: 2635588 • Views: 134

More Releases from UnivDatos Market Insights (UMI)

Healthcare Consulting Services Market Size, Share, Growth 2021-2027 | Cognizant, …
A comprehensive overview of the healthcare consulting services market is recently added by UnivDatos Market Insights to its humongous database. The healthcare consulting services market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the Healthcare Consulting Services market. The healthcare consulting services market report offers a
Greenhouse Film Market Size, Share, Growth, Trend 2021-2027 | Key Players Are Gi …
A comprehensive overview of the global Greenhouse Film market is recently added by UnivDatos Market Insights to its humongous database. The report has been aggregated by collecting informative data from various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the Greenhouse Film market globally. This report offers a detailed analysis of the latest industry developments and
Automotive Data Logger Market: Research Strategies with Share Analysis, Top Key …
Modern car data loggers are more expensive than traditional OBD-I systems. However, data loggers that simply support CAN and LIN channels are less expensive than those that handle all of the major channels (CAN, LIN, FlexRay, and Ethernet). This is also dependent on the amount of analog and digital inputs that data loggers can accommodate. OEMs are always pressuring data logger vendors to reduce device pricing while preserving device quality.
Microbiology Culture Market: Research Strategies with Share Analysis, Top Key Pl …
There has been an increase in the global market for microbial culture due to the rise in antibiotic demand owing to the rise in infectious diseases such as HIV/AIDS, Tuberculosis, and Viral Hepatitis. For instance, as per the CDC, in the United States around 7,100 number are reported Tuberculosis (TB) in 2020 (a rate of 2.2 per 100,000 persons) which increased to around 7,800 number is reported TB cases in

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business